title: Should we screen for coronary artery disease in asymptomatic chronic dialysis patients?
abstract: The hemodialysis population is characterized by a high prevalence of 'asymptomatic' coronary artery disease (CAD), which should be interpreted differently from asymptomatic disease in the general population. A hemodynamically significant stenosis may not become clinically apparent owing to impaired exercise tolerance and autonomic neuropathy. The continuous presence of silent ischemia may cause heart failure, arrhythmias, and sudden death. Whether revascularization of an asymptomatic dialysis patient improves outcome remains a moot point, although several observational studies and one small RCT suggest a benefit. It can therefore be defended to screen asymptomatic dialysis patients for CAD. A number of noninvasive screening tests are available, but none has proved equally practical and reliable in the dialysis population as in the general population. Myocardial perfusion scintigraphy (MPS) before and after a pharmacological stress such as dipyridamole can reveal both ischemia and myocardial scarring. When compared with coronary angiography, low sensitivities were reported and attributed to impaired vasodilation to dipyridamole in dialysis patients. A more likely explanation is that not every anatomical stenosis will lead to impaired coronary blood flow on MPS. Numerous studies have shown an incremental prognostic value of dipyridamole-MPS over clinical data for prediction of adverse cardiac events, in some studies even over coronary angiography. Pending the availability of high-quality evidence, in our opinion asymptomatic dialysis patients could undergo dipyridamole-MPS, followed by coronary angiography in case of an abnormal scan. This combined physiological and anatomical evaluation of the coronary circulation allows us to determine which coronary stenosis is clinically relevant and therefore should be revascularized.
authors.affiliation: Renal Unit, Department of Internal Medicine, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium. an.devriese@azsintjan.be
authors.forename: An S
authors.initials: AS
authors.lastname: De Vriese
authors.forename: Stefaan J
authors.initials: SJ
authors.lastname: Vandecasteele
authors.forename: Barbara
authors.initials: B
authors.lastname: Van den Bergh
authors.forename: Frank W
authors.initials: FW
authors.lastname: De Geeter
mesh_terms: D058070:Asymptomatic Diseases / Q000453:epidemiology*; D003324:Coronary Artery Disease / Q000175:diagnosis* / Q000453:epidemiology*; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D015995:Prevalence; D006435:Renal Dialysis